Log In
BCIQ
Print this Print this
 

CEL-2000

  Manage Alerts
Collapse Summary General Information
Company Cel-Sci Corp.
DescriptionVaccine formulated using Ligand Epitope Antigen Presentation System (L.E.A.P.S.) T cell modulation platform technology
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today